SiRNA in MSC-derived exosomes silences CTGF gene for locomotor recovery in spinal cord injury rats
Abstract Background How to obtain a small interfering RNA (siRNA) vector has become a moot point in recent years. Exosomes (Exo) show advantages of long survival time in vivo, high transmission efficiency, and easy penetration across the blood-spinal cord barrier, renowned as excellent carriers of b...
Main Authors: | Wei Huang, Mingjia Qu, Lu Li, Tao Liu, Miaoman Lin, Xiaobing Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02401-x |
Similar Items
-
The optimal concentration of siRNA for gene silencing in primary cultured astrocytes and microglial cells of rats
by: Kyeong Ho Ki, et al.
Published: (2010-12-01) -
siRNA Versus miRNA as Therapeutics for Gene Silencing
by: Jenny K W Lam, et al.
Published: (2015-01-01) -
siRNA for Influenza Therapy
by: Sailen Barik
Published: (2010-07-01) -
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
by: Dima Hattab, et al.
Published: (2021-07-01) -
Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges
by: Hara Kang, et al.
Published: (2023-10-01)